Article Details
Retrieved on: 2024-10-19 14:36:09
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details DBV Technologies' participation in the ACAAI Congress, focusing on peanut allergy treatments, and highlights its stock market presence. This aligns with the tags related to allergies, immunology, and DBV's market activities.
Article found on: live.euronext.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here